Montaser F. Shaheen, MD

  • Associate Professor, Medicine

A member of the UA Cancer Center and UA Skin Cancer Institute, Dr. Shaheen received his medical degree from Damascus University in Syria, and then went on to complete his residency and internship at Southern Illinois University School of Medicine, Springfield, Ill, specializing in internal medicine. He completed his fellowship at Indiana University Medical Center, specializing in hematology/oncology. Dr. Shaheen is certified by the American Board of Internal Medicine in hematology and medical oncology. 

Research Interests: 

Melanoma

Residency
  • Southern Illinois University School of Medicine, Springfield, IL
Fellowship
  • Indiana University Medical Center - Clarian, Indianapolis, IN, Specialty in Hematology/Oncology
Board Certifications
  • American Board of Internal Medicine (Sub: Hematology) (2003)
  • ABIM (Sub: Medical Oncology) (2003)

Select Publications

2017

Infante, J. R., A. Patnaik, C. F. Verschraegen, A. J. Olszanski, M. Shaheen, H. A. Burris, A. W. Tolcher, K. P. Papadopoulos, M. Beeram, S. M. Hynes, et al., "Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer.", Cancer Chemother Pharmacol, vol. 79, issue 2, pp. 315-326, 2017 Feb. PMID: 28097385

2016

Reynolds, S., M. Shaheen, G. Olson, M. Barry, J. Wu, and T. Bocklage, "A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off.", Head Neck Pathol, vol. 10, issue 3, pp. 405-13, 2016 Sep. PMCID: PMC4972767  PMID: 27075025
F Hodi, S., J. Chesney, A. C. Pavlick, C. Robert, K. F. Grossmann, D. F. McDermott, G. P. Linette, N. Meyer, J. K. Giguere, S. S. Agarwala, et al., "Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.", Lancet Oncol, vol. 17, issue 11, pp. 1558-1568, 2016 Nov. PMID: 27622997

2015

Postow, M. A., J. Chesney, A. C. Pavlick, C. Robert, K. Grossmann, D. McDermott, G. P. Linette, N. Meyer, J. K. Giguere, S. S. Agarwala, et al., "Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.", N Engl J Med, vol. 372, issue 21, pp. 2006-17, 2015 May 21. PMID: 25891304

2014

Shanmugam, I., M. Abbas, F. Ayoub, S. Mirabal, M. Bsaili, E. K. Caulder, D. M. Weinstock, A. E. Tomkinson, R. Hromas, and M. Shaheen, "Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination.", J Biol Chem, vol. 289, issue 33, pp. 22739-48, 2014 Aug 15. PMCID: PMC4132780  PMID: 24923443